Mitem Pharma
PrivateLast Round
Corporate Funding
Sep 25, 2024
Total Funding Raised
$10.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mitem Pharma operates in Healthcare & Life Sciences and is based in Massy. Its latest recorded funding round was a Corporate Funding round in September 2024.
Mitem Pharma is a pharmaceutical company that specializes in the revitalization, development, and commercialization of drugs of major therapeutic interest (MITMs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitem Pharma Comparables
Compare Mitem Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laboratoires Delbert | 86% | |
| Essential Pharma | 80% | |
| Pharmanovia | 78% |
For institutional investors. Book with your work email.
Mitem Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 25, 2024 | ||||
| Growth Equity | Apr 25, 2022 |
For institutional investors. Book with your work email.
Mitem Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Capital Partners | Corporate Funding |
| TechLife Capital | Corporate Funding, Growth Equity |
| SWEN Capital Partners | Corporate Funding |
| MACSF | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 89% MoM, from 782 to 1.5K.
- Jan 7, 2026
Monthly visitors grew 464% MoM, from 83 to 468.
For institutional investors. Book with your work email.
Mitem Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mitem Pharma's valuation, stock price, and market status.
Is Mitem Pharma a public or private company?
Mitem Pharma is a private company.
What is the current stock price of Mitem Pharma?
Mitem Pharma is a private company, so its shares have no public market price. Caplight tracks Mitem Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mitem Pharma worth (valuation)?
Valuation information for Mitem Pharma is not publicly available.
Can I buy Mitem Pharma stock?
Mitem Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mitem Pharma's last funding round?
Mitem Pharma's most recent funding round was Corporate Funding on September 25, 2024.
Who are the main investors in Mitem Pharma?
Key investors in Mitem Pharma include TechLife Capital.
Will Mitem Pharma IPO soon?
No public IPO plans have been announced for Mitem Pharma.
How can I track Mitem Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Mitem Pharma's shares on secondary markets.